this bird will fly soon

todays announcement which was a transcript of last weeks brr discussion spells it out for cmp.

it now has a product that is capable of challenging the likes of rmd in the treatment of sleep apnoea. rmd has a market cap close to $4 billion....

with a decent size chunk of the diagnostics business already cmp is extremely well positioned for growth going forward. the half yearly revenues it reports testify to this fact and in fact, the company is even profitable already.

current market cap is just too low, especially given the increasing sentiment we are seeing for biotechs, ems, agx, acl in the past few weeks. cmp could easily rise to 30 to 40cps within the next couple of weeks without suprising me.